This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (7)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Lynne Lamberg
JAMA contributor

JAMA. 1998;280:867-869.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

PSYCHIATRIC ISSUES tied to the use of oral sildenafil (Viagra) for erectile dysfunction (ED) provoked strong interest at the annual meeting of the American Psychiatric Association (APA) in Toronto, Ontario, in June. Psychiatrists' craving for information, however, went unrequited. There were no formal presentations on ED, perhaps because Viagra had been approved for sale in the United States only in March. In the meeting's commercial exhibit area, representatives of the drug's manufacturer, Pfizer Inc, New York, NY, claimed they could not answer questions because the drug was not available in Canada.

But psychiatrists and other therapists specializing in the diagnosis and treatment of sexual dysfunction said in interviews that the brain, arguably the body's chief sex organ, is likely to play a potent role in the long-term success of this and other medications being developed to treat ED. Now that an easy-to-use medication is available, specialists said, men . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Diffusion of a Novel Therapy Into Clinical Practice: The Case of Sildenafil
Harrold et al.
Arch Intern Med 2000;160:3401-3405.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of Sildenafil
Smith and Roberts
ANN INTERN MED 2000;132:933-937.
ABSTRACT | FULL TEXT